Precision Therapy that Works for All Ever Supreme Biotechnology presents the CAR.BiTE Immunotherapy Strategy against Solid Tumors.
The Objective of this Innovation: A single pipeline of immunotherapy that can help all cancer patients, despite tumor type and genetic background.
Key Achievements: Our CAR.BiTE design with aiming to immune checkpoint protein (ICP) can bring many benefits to switching the tumor microenvironment and increasing the bystander effect of anti-ICP in the local tumor site.
